LENZ (LENZ Therapeutics) Inventories, Raw Materials & Components: $2.24 Mil (As of Mar. 2026)


LENZ LENZ Therapeutics Inc LENZ
12 GF Score
Price $5.82
! 2 Warning Signs
View Full Analysis

What is LENZ Therapeutics Inventories, Raw Materials & Components?

LENZ Therapeutics LENZ +5.63% 12 Inventories, Raw Materials & Components is $2.24 Mil as of Mar. 2026. GuruFocus rates LENZ with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

LENZ Therapeutics's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $2.24 Mil.

LENZ Therapeutics's quarterly raw materials increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($2.76 Mil) but then declined from Dec. 2025 ($2.76 Mil) to Mar. 2026 ($2.24 Mil).

LENZ Therapeutics's annual raw materials stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($2.76 Mil).

LENZ Therapeutics Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for LENZ Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LENZ Therapeutics Inventories, Raw Materials & Components Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00 2.76

LENZ Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 2.76 2.24
LENZ
12GF Score
LENZ Therapeutics Inc LENZ
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LENZ Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $2.24 Mil mean?
LENZ Therapeutics (LENZ) has a Inventories, Raw Materials & Components of $2.24 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on LENZ Therapeutics and its competitors.
Is LENZ Therapeutics' Inventories, Raw Materials & Components too high?
LENZ Therapeutics' current Inventories, Raw Materials & Components is $2.24 Mil. Overall, LENZ Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does LENZ Therapeutics' Inventories, Raw Materials & Components compare to KRRO and ANTX?
LENZ Therapeutics' Inventories, Raw Materials & Components of $2.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on LENZ Therapeutics and its competitors. LENZ Therapeutics's current Inventories, Raw Materials & Components is $2.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LENZ Therapeutics stock overvalued right now?
LENZ Therapeutics (LENZ) has a current Inventories, Raw Materials & Components of $2.24 Mil. The current Inventories, Raw Materials & Components is $2.24 Mil. LENZ Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For LENZ Therapeutics (LENZ), the current Inventories, Raw Materials & Components is $2.24 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LENZ Therapeutics Business Description

Address 201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
12GF Score

Get the complete analysis for LENZ

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.82
Price